David E. Kang
Impact in
- Physiology top 0.5%
- Alzheimer's disease research and treatments
- Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Physiology 46
- Alzheimer's disease research and treatments 43
-
- Nuclear Receptors and Signaling 6
- Co-authors
- Edward H. Koo (16 shared papers)Jung A. Woo (36 shared papers)Claus U. Pietrzik (3 shared papers)Salvador Soriano (5 shared papers)Eliezer Masliah (6 shared papers)Yu Xia (3 shared papers)Rong Wang (1 shared paper)Sascha Weggen (1 shared paper)
- Journals
- The FASEB Journal (6 papers)Journal of Biological Chemistry (6 papers)Proceedings of the National Academy of Sciences (4 papers)The Journal of Urology (3 papers)Cell Death and Disease (3 papers)
- Partner nations
- United StatesFranceTürkiye
In The Last Decade
David E. Kang
77 papers receiving 5.6k citations
David E. Kang's Hit Papers
Peers
Comparison fields: 5 of 126
- Physiology 3.0k
- Neurology 676
- Biological Psychiatry 180
- Cellular and Molecular Neuroscience 1.2k
- Pharmacology 868
Countries citing papers authored by David E. Kang
This map shows the geographic impact of David E. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kang more than expected).
Fields of papers citing papers by David E. Kang
This network shows the impact of papers produced by David E. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kang. The network helps show where David E. Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity Hit paper breakdown → | 2001 | 1208 |
| 2 | 1997 | 353 | |
| 3 | 2000 | 310 | |
| 4 | 1997 | 275 | |
| 5 | 2004 | 235 | |
| 6 | 2002 | 207 | |
| 7 | 2001 | 187 | |
| 8 | 2010 | 180 | |
| 9 | 1995 | 180 | |
| 10 | 1999 | 170 | |
| 11 | 1999 | 151 | |
| 12 | 2005 | 127 | |
| 13 | 2017 | 103 | |
| 14 | 2022 | 102 | |
| 15 | 2005 | 99 | |
| 16 | 2007 | 96 | |
| 17 | 2008 | 90 | |
| 18 | 2012 | 84 | |
| 19 | 2015 | 79 | |
| 20 | 2009 | 75 |
About David E. Kang
David E. Kang is a scholar working on Physiology, Cellular and Molecular Neuroscience, Molecular Biology, Neurology and Cell Biology, having authored 79 papers that have together received 5.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (43 papers), Cellular transport and secretion (10 papers), Mitochondrial Function and Pathology (8 papers), Nuclear Receptors and Signaling (6 papers), Wnt/β-catenin signaling in development and cancer (6 papers), Amyotrophic Lateral Sclerosis Research (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and S100 Proteins and Annexins (6 papers). The work is most often cited by research in Physiology (3.0k citations), Neurology (676 citations), Biological Psychiatry (180 citations), Cellular and Molecular Neuroscience (1.2k citations) and Pharmacology (868 citations). David E. Kang has collaborated with scholars based in United States, France and Türkiye. Frequent co-authors include Edward H. Koo, Jung A. Woo, Claus U. Pietrzik, Salvador Soriano, Eliezer Masliah, Yu Xia, Rong Wang, Sascha Weggen, Pritam Das and Jason L. Eriksen. Their work appears in journals such as The FASEB Journal, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, The Journal of Urology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.